NurseWeek

British company will work on West Nile virus vaccine

Wire Services
August 1, 2000


	You've read the article. Now tell us what you think. Related Sites CDC prevention of West Nile virus FAQs answered by the Epidemiology and Disease Control Program

London. A U.S. grant of nearly $3 million was given to Britain's Peptide Therapeutics Plc today to develop a vaccine against the deadly West Nile virus.

Peptide will receive an up-front payment of $263,000 to cover the first eight months of its work. Following successful completion of the first phase, the National Institutes of Health will make another payment of $2.7 million spread over two years, Peptide said in a statement.

The lethal virus, which is carried by mosquitoes, struck New York last summer, killing seven people.

Two dead crows infected with the virus were discovered in Boston in July and West Nile virus warnings have been issued along the eastern seaboard that stretches from New Jersey to New York.

Read the full article